Levetiracetam Sandoz

Levetiracetam, the active ingredient in Levetiracetam Sandoz, is an antiepileptic presented as an oral dosage form for systemic use. It is prescribed to manage seizure activity in patients with epilepsy, including partial and generalized tonic‑clonic seizures, and serves as adjunct therapy for various seizure types.

GNH USA supplies Levetiracetam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity across EU and global markets. The company adheres to stringent quality standards, provides documentation, and supports regulatory submissions, making it a reliable source for bulk and patient‑level distribution.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in epilepsy.

- Partial onset seizures: decreases frequency of focal seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes. - Myoclonic seizures: used as adjunct therapy to reduce myoclonic events.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: generalized tiredness or lack of energy. - Somnolence: increased sleepiness, especially after dose initiation. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare but life‑threatening skin disorder. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Blood dyscrasias: unusual bruising or bleeding. - Multi‑organ failure: extremely rare systemic involvement.

When prescribing levetiracetam, several safety considerations should be observed.

- Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver enzymes regularly. - Pregnancy: discuss potential risks with the prescriber, as safety data are limited. - Breastfeeding: evaluate benefits versus potential infant exposure. - Psychiatric symptoms: monitor for mood changes, depression, or aggression. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenytoin: can lower levetiracetam levels, decreasing efficacy. - Phenobarbital: strong enzyme inducer that may diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression, increasing sedation. - Other antiepileptics: may require dose adjustments to maintain seizure control. - Oral contraceptives: levetiracetam may reduce hormonal contraceptive effectiveness.